|
|
Article: Research and Markets: Available Now - Optimer Pharmaceuticals Inc: Premium Company Profile.(Company overview)
- Article from:
- Business Wire
- Article date:
- September 1, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/8dc894/optimer_pharmaceut) has announced the addition of the "Optimer Pharmaceuticals Inc: Premium Company Profile" company profile to their offering.
Optimer is a biopharmaceutical company focused on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The Company currently has two late stage anti-infective product candidates, OPT-80 (Difimicin) and Prulifloxacin, at Phase III trials.
Scope:
- Contains corporate strategy, value chain presence and SWOT Analysis
- Provides ...